Key
Questions About the
COPD
GeneTM
Research Study
Why
is it important to understand the genetics
of COPD?
Much
of what we know about the genetics of COPD has come
from a relatively rare inherited
disorder called alpha-1 antitrypsin
deficiency.
By
identifying other inherited factors, we will
better understand the other causes of COPD. This
improved understanding will lead
to better treatments for COPD.
Avoiding
tobacco smoke will always be the most
important way to prevent COPD, but for
the millions of Americans who already have
COPD, additional research is urgently
needed.
What
is unique about the study?
There
are many unique aspects to this study:
-
It
is the largest study ever of the causes of COPD:
We will enroll 6000 people with
COPD and 4500 current or former smokers
without COPD.
-
State
of the art x-ray CT scans of the chest
will be performed.
-
A
comprehensive search for genetic differences.
-
This
is one of the first studies of COPD to
include a large percentage of African American
participants.
-
People
with very mild to very severe COPD
will be included.
Who
is funding the study?
This
study is funded by a grant from the National Heart,
Lung, and Blood Institute of
the National Institutes of Health.
Will
research information be kept confidential?
We
will use state-of-the-art security measures to keep
individual identity information
confidential.
How
long does it take to participate in the COPDGeneTM
research study?
One
to two visits at a clinical center last in
total about three to four hours, and include
breathing tests, questionnaires, blood
samples, and a chest CT Scan.
Who
is involved with this study?
This
study involves many leading medical centers.
In order to make it easier for people
to participate, clinical centers are located
throughout the country.
Will
I be compensated for my participation?
Modest
compensation for your time and inconvenience will be
provided.